Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · The Lancet · 1,818 citations
https://doi.org/10.1016/s0140-6736(21)00676-0
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
5
Papers
46
Citations
2
h-index
2
i10-index
Ali Khan is an academic researcher from Quaid-i-Azam University. The author has contributed to research in topics: Essential Oils and Antimicrobial Activity & Drug-Induced Hepatotoxicity and Protection & Allelopathy and phytotoxic interactions. The author has an h-index of 2, co-authored 5 publications.
Click to start Chat